Desmond Tutu HIV Foundation   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Cape Town South Africa (1990)

Organization Overview

First Clinical Trial
2005
NCT00888446
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Desmoid Tumor Research Foundation | Desmond Tutu HIV Centre Cape Town | Desmond Tutu HIV Foundation | Desmond Tutu HIV Foundation-Emavundleni Research Center

Active Ingredients

Drugs in Phase 4 Trials (2)

emtricitabine (emtriva) (3 trials)

tenofovir (viread) (4 trials)

Drugs in Phase 3 Trials (2)

cabotegravir (Vocabria) (1 trial)

tenofovir alafenamide (genvoya) (1 trial)

Drugs in Phase 2 Trials (2)

sirolimus (rapamune) (1 trial)

tgaac09 (1 trial)

Drugs in Phase 1 Trials (4)

ad26.enva.01 vaccine (1 trial)

ad35-env (1 trial)

h4 (1 trial)

ic31 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

Communicable Diseases (Phase 2)

Fibroma (Phase 2)

Fibromatosis, Aggressive (Phase 2)

HIV Infections (Phase 2)

Infections (Phase 2)

Tuberculosis (Phase 1)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 10